Supplementary Table.
Clinical Profile of patients in this study
| Patient
No. |
Age | Parity | GA | Int. 1 | Int. 2 | NS1 | Infection | Platelet
(×103 cells/μl) |
Hct
(%) |
AST
(IU/l) |
ALT
(IU/l) |
Bleeding | BT | BT-pre | PROM | MOD | Birth
weight (g) |
Ap1/5 | PPH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 24 | 1 | 38w4d | 5 | 5 | N | Primary | 12 | 39 | 90 | 34 | Pet, B | Yes | No | Yes | VD | 3150 | 8/9 | Yes |
| 2 | 20 | 0 | 38w2d | 5 | 5 | P | Primary | 40 | 39.7 | 1526 | 934 | N | Yes | No | No | CS | 3600 | 6/8 | Yes |
| 3 | 27 | 3 | 39w0d | 3 | 3 | P | Primary | 57 | 30 | 53 | 11 | N | Yes | No | No | VD | 2900 | 8/9 | Yes |
| 4 | 24 | 0 | 36w6d | 10 | 7 | P | Primary | 19 | 39 | ND | ND | Pet | Yes | Yes | Yes | VD | 3000 | 8/9 | No |
| 5 | 31 | 1 | 33w6d | 4 | 4 | P | Primary | 36 | 37.8 | ND | ND | Pet | Yes | Yes | No | VD | 2250 | 7/8 | No |
| 6 | 28 | 0 | 39w5d | 3 | 2 | P | Primary | 37 | 39 | 39 | 40 | Pet | Yes | Yes | Yes | VD | 3000 | 8/9 | No |
| 7 | 26 | 1 | 39w6d | 6 | 6 | P | Secondary | 39 | 42 | 117 | 49 | Pet | No | No | No | VD | 3300 | 8/9 | No |
| 8 | 33 | 1 | 40w1d | 5 | 3 | P | Primary | 52 | 41.1 | ND | ND | N | No | No | Yes | VD | 3600 | 8/9 | No |
| 9 | 22 | 0 | 37w6d | 7 | 6 | P | Primary | 68 | 41.7 | ND | ND | N | No | No | No | VD | 3100 | 8/9 | No |
| 10 | 22 | 0 | 37w3d | 7 | 7 | P | Secondary | 72 | 38.8 | ND | ND | N | No | No | Yes | VD | 2200 | 8/9 | No |
| 11 | 25 | 0 | 39w1d | 3 | 3 | P | Primary | 80 | 39.6 | 39 | 15 | N | No | No | No | VD | 3100 | 8/9 | No |
| 12 | 20 | 0 | 36w3d | 10 | 9 | P | Primary | 90 | 40.1 | ND | ND | Pet | No | No | Yes | CS | 2400 | 6/7 | No |
| 13 | 25 | 0 | 38w2d | 9 | 9 | N | Primary | 100 | 41.3 | ND | ND | N | No | No | Yes | CS | 3100 | 7/8 | No |
| 14 | 23 | 0 | 39w0d | 5 | 3 | P | Primary | 114 | 36.2 | 33 | 13 | N | No | No | No | VD | 3000 | IUFD | No |
| 15 | 22 | 0 | 39w4d | 3 | 3 | P | Primary | 120 | 33.6 | 37 | 9 | N | No | No | No | VD | 2600 | 8/9 | No |
| 16 | 30 | 1 | 39w0d | 2 | 2 | P | Primary | 140 | 29.5 | 19 | 9 | N | No | No | No | VD | 3600 | 8/9 | No |
| 17 | 22 | 0 | 39w4d | 2 | 2 | P | Primary | 145 | 30.1 | 41 | 16 | N | No | No | No | VD | 2950 | 7/8 | No |
| 18 | 28 | 1 | 38w3d | 6 | 6 | P | Primary | 145 | 41.6 | ND | ND | Pet | No | No | No | VD | 3350 | 8/9 | No |
| 19 | 21 | 0 | 39w6d | 4 | 3 | P | Primary | 184 | 42.5 | 47 | 15 | N | No | No | No | CS* | 3200 | 7/8 | No |
| 20 | 23 | 0 | 34w6d | ND | ND | P | Primary | 374 | 32.5 | ND | ND | N | No | No | Yes | VD | 2600 | 8/9 | No |
Abbreviations: GA, gestational age at delivery; Int. 1, interval between onset of symptom and diagnosis; Int. 2, interval between onset of symptom and delivery; Hct, hematocrit; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BT, platelet transfusion; BT-pre, platelet transfusion before delivery; PROM, premature rupture of membrane; MOD, mode of delivery; Ap1/5, Apgar scores at 1/5minutes; PPH, postpartum hemorrhage; Pet, petechial; B, bleeding in oral cavity; N, negative; P, positive; VD, vaginal delivery; CS, Cesarean section; ND, not determined; IUFD, intrauterine fetal death
*category III for fetal heart monitoring.